577 filings
Page 5 of 29
8-K
vkixqmcs
27 Mar 20
Results of Operations and Financial Condition
7:20am
8-K
at76offfjes
13 Nov 19
Altimmune Announces Third Quarter 2019 Financial Results and Provides a Business Update
4:20pm
8-K
xc3zj nhsxw02vc
1 Oct 19
Departure of Directors or Certain Officers
4:06pm
UPLOAD
hszoxb2t
22 Aug 19
Letter from SEC
12:00am
8-K
o3kuwhr cm0
21 Aug 19
Altimmune Announces $3.7 Million in Additional BARDA Funding to Advance NasoShield™Clinical Development
7:05am
CORRESP
mggfvh8heudwx57
19 Aug 19
Correspondence with SEC
12:00am
UPLOAD
my876txqehnwrvm5gy
16 Aug 19
Letter from SEC
12:00am
S-8
6whtqj fm
14 Aug 19
Registration of securities for employees
12:00am
8-K
mszy49b0ijj4
13 Aug 19
Altimmune Announces Second Quarter 2019 Financial Results and Provides a Business Update
4:21pm
8-K
fjjzydfkzp 847q
15 Jul 19
Completion of Acquisition or Disposition of Assets
7:22am
8-K
j46voq3 0d16d24
9 Jul 19
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
7:58am
8-K
odf92cw40
21 Jun 19
Departure of Directors or Certain Officers
4:47pm
8-K
4gohh 29pgpy8
12 Jun 19
Altimmune Appoints Will Brown as Chief Financial Officer
4:02pm
8-K
uutlde0i tmygq66l
7 Jun 19
Departure of Directors or Certain Officers
4:02pm
8-K
6grm43t61r1cepmvnl6
14 May 19
Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update
4:15pm